Trial Profile
A phase II study of induction chemotherapy with paclitaxel and carboplatin followed by radiotherapy plus RSR13 [efaproxiral] for locally advanced inoperable non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Aug 2021
Price :
$35
*
At a glance
- Drugs Carboplatin; Efaproxiral; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 15 Sep 2005 New trial record.